{
    "2019-11-27": [
        [
            {
                "time": "2018-11-15",
                "original_text": "FOCUS-Pfizer, Novartis lead $2 bln spending spree on gene therapy production",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Novartis",
                        "spending spree",
                        "gene therapy"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-11-15",
                "original_text": "Pfizer, Novartis lead $2 billion spending spree on gene therapy production",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Novartis",
                        "spending spree",
                        "gene therapy"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-11-15",
                "original_text": "FOCUS-Pfizer, Novartis lead pharma spending spree on gene therapy production",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Novartis",
                        "spending spree",
                        "gene therapy"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-11-25",
                "original_text": "Global Blood's (GBT) Oxbryta Secures FDA Approval for SCD",
                "features": {
                    "keywords": [
                        "Global Blood",
                        "Oxbryta",
                        "FDA Approval",
                        "SCD"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-11-25",
                "original_text": "Why Biotech ETFs Surged in Monday's Trading Session",
                "features": {
                    "keywords": [
                        "Biotech ETFs",
                        "Surged",
                        "Trading Session"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}